PHASE I STUDY OF BENDAMUSTINE, RITUXIMAB, IBRUTINIB, AND VENETOCLAX IN RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA. (17th June 2021)

Record Type:: Journal Article
Title:: PHASE I STUDY OF BENDAMUSTINE, RITUXIMAB, IBRUTINIB, AND VENETOCLAX IN RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA. (17th June 2021)
Main Title:: PHASE I STUDY OF BENDAMUSTINE, RITUXIMAB, IBRUTINIB, AND VENETOCLAX IN RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA
Authors:: Kumar, A.
Batlevi, C.
Drullinsky, P.
Grieve, C.
Laraque, L.
Joseph, A.
Mahajan, N.
Matasar, M.
Straus, D.
Zelenetz, A.
Hamlin, P.
Abstract:
Is Part Of:: Hematological oncology. Volume 39(2021)Supplement 2
Journal:: Hematological oncology
Issue:: Volume 39(2021)Supplement 2
Issue Display:: Volume 39, Issue 2 (2021)
Year:: 2021
Volume:: 39
Issue:: 2
Issue Sort Value:: 2021-0039-0002-0000
Page Start:: n/a
Page End:: n/a
Publication Date:: 2021-06-17
Subjects:: Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.88_2881 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24541.xml